ECM1 and neoplasm: A selection of the proteins from this panel are of high abundance in plasma (i.e., C3 and SERPINA1), while others are not (i.e., PF4 and ECM1), and so reflect the contributions of localized changes due to tumor presence and anti-tumor immunity.